Share on StockTwits

Vascular Solutions (NASDAQ:VASC) was upgraded by Zacks from an “underperform” rating to a “neutral” rating in a report released on Tuesday. The firm currently has a $21.80 target price on the stock. Zacks‘s price target suggests a potential upside of 2.54% from the company’s current price.

Vascular Solutions (NASDAQ:VASC) remained flat at $21.26 during during mid-day trading trading on Tuesday. 24,608 shares of the company’s stock traded hands. Vascular Solutions has a 1-year low of $13.92 and a 1-year high of $28.21. The stock has a 50-day moving average of $20.64 and a 200-day moving average of $23.1. The company has a market cap of $364.1 million and a price-to-earnings ratio of 31.31.

Vascular Solutions (NASDAQ:VASC) last released its earnings data on Tuesday, April 22nd. The company reported $0.16 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.18 by $0.02. The company had revenue of $29.91 million for the quarter, compared to the consensus estimate of $29.91 million. During the same quarter in the prior year, the company posted $0.16 earnings per share. The company’s quarterly revenue was up 14.7% on a year-over-year basis. Analysts expect that Vascular Solutions will post $0.72 EPS for the current fiscal year.

Vascular Solutions, Inc (NASDAQ:VASC) is a medical device company focused on providing clinically advanced solutions to interventional cardiologists and interventional radiologists.

To view Zacks’ full report, visit Zacks’ official website.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.